Publication | Open Access
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
62
Citations
28
References
2021
Year
GlaxoSmithKline Biologicals SA, Bill and Melinda Gates Foundation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1